HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amanda B Pilling Selected Research

Neoplasms (Cancer)

2/2018ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.
6/2010Folate deficiency provides protection against colon carcinogenesis in DNA polymerase beta haploinsufficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amanda B Pilling Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 06/2017
2Neoplasms (Cancer)
02/2018 - 06/2010
2Carcinogenesis
01/2011 - 06/2010
1Lung Neoplasms (Lung Cancer)
02/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012
1Lymphoma (Lymphomas)
06/2010
1Adenocarcinoma
06/2010

Drug/Important Bio-Agent (IBA)

2enzalutamideIBA
01/2019 - 06/2017
2CrizotinibIBA
02/2018 - 03/2012
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2011 - 06/2010
1Anaplastic Lymphoma KinaseIBA
02/2018
1Androgen Receptors (Androgen Receptor)IBA
06/2017
1Inhibitor of Apoptosis ProteinsIBA
06/2017
11,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
06/2010
1DNA Polymerase beta (DNA Polymerase IV)IBA
06/2010

Therapy/Procedure

2Castration
01/2019 - 06/2017